Tuesday, December 29, 2009

From Twitter 12-28-2009

Tweets copied by twittinesis.com

buzz this

Monday, December 28, 2009

From Twitter 12-27-2009

  • 11:39:02: 2010 New Year's Resolutions in THS: Play soccer again. Invent a digital tool. Travel somewhere warm. #2010NYHaiku; rules www.2010nyhaiku.com
  • 12:09:51: Seriously, watch this all the way through. So sweet. http://bit.ly/53gUK3

Tweets copied by twittinesis.com

buzz this

Friday, December 25, 2009

From Twitter 12-24-2009

  • 17:41:55: Merry Christmas and happy holidays everyone :)

Tweets copied by twittinesis.com

buzz this

Thursday, December 24, 2009

From Twitter 12-23-2009

  • 09:08:01: Are celebrities crossing the line on medical advice? http://usat.me/?37090910
  • 09:08:46: Don't believe medical advice from Internet, celebs when ... http://usat.me/?37089762 #fdasm
  • 10:40:45: VERIZON vs AT&T. Fascinating article. Independent tests show REAL prob is iPhone, not AT&T, but AT&T can't say that. http://bit.ly/7zYvNn
  • 10:53:23: Apparently, if it wasn't 4 SF's & NYC's terrible coverage (admitted 2 by AT&T) + iphone's "packet" issues, AT&T would win hands down vs VRZ
  • 11:29:32: Has anyone used SQUARESPACE before? If so, what are thoughts? Compared to Blogger & Wordpress? Thanks!
  • 14:44:10: @billmix Tha's what I've heard. All of a sudden, I'm hearing of squarespace everywhere. I guess the company is "tipping".
  • 15:23:57: Submitted to FDA docket, Brodeur Partners & UNC Social Work: "e-Patient Communities and Chronic Illness": http://bit.ly/7GXn1S #fdasm
  • 15:30:39: FDA responds to the #FDASM Community's questions re: "next steps" for Internet & Social Media Guidelines: http://bit.ly/8735Ip Pls RT
  • 17:59:14: Re: FDA's "response" to #fdasm community questions. For me, the dialogue IS the message. Think positive. Happy holidays friends!

Tweets copied by twittinesis.com

buzz this

Wednesday, December 23, 2009

The FDA Responds to Questions from FDASM Community About “Next Steps” for Internet & Social Media guidelines of FDA-regulated products

The following was received 12/23/2009 @ 1 PM EST along with a 10-PAGE PDF RESPONSE.

Click here to download the PDF.

# # #

Dear Fabio and the FDASM Community,

Thank you for submitting your questions. We found them to be useful in identifying general issues for policy development. However, please note that we are unable to provide additional comments on some of the questions in this forum as we need to adhere to FDA's Good Guidance Practices (GGP's).

FDA welcomes research, data, and comments from its stakeholders and the public on any current issues related to Internet and social media promotion and adverse event reporting of FDA-regulated medical products and encourages submissions of written and electronic comments to this docket, which closes on February 28, 2010. We are committed to getting the best information as possible in helping inform our policy. Once the docket closes and we review all the comments, we will be able to determine next steps.

Again, we appreciate your continue support of this important endeavor, which we believe will aid FDA in achieving its objective of ensuring that consumers and healthcare professionals have access to accurate, balanced, and timely information about medical products.

Kind regards,

Thomas Abrams, Director, Division of Drug Marketing, Advertising, and Communications (DDMAC)

Kristin Davis, Deputy Director, DDMAC

Mark Askine, Associate Director, DDMAC

Jean-Ah Kang, Special Assitant to the Director, DDMAC

buzz this

From Twitter 12-22-2009

Tweets copied by twittinesis.com

buzz this

Tuesday, December 22, 2009

From Twitter 12-21-2009

Tweets copied by twittinesis.com

buzz this

Monday, December 21, 2009

From Twitter 12-20-2009

Tweets copied by twittinesis.com

buzz this

Sunday, December 20, 2009

From Twitter 12-19-2009

Tweets copied by twittinesis.com

buzz this

Saturday, December 19, 2009

From Twitter 12-18-2009

  • 08:06:03: @andrewspong @whydotpharma - thanks for all the kind words this morning!!! So, what next? #hcsmeu #fdasm
  • 09:00:12: Ryan Squire @osusquire shares Ohio State's involvement & POV in social media & healthcare via slideshare: http://bit.ly/5ca40Y #fdasm
  • 09:37:17: Abltly! RT @OSUSquire SM marries well w/ idea of personalized health care... it can help us build relationship base that is essential #fdasm

Tweets copied by twittinesis.com

buzz this

Friday, December 18, 2009

From Twitter 12-17-2009

  • 08:35:44: Terrific! RT @EileenOBrien: Starting #SocPharm chat on Weds at 8pm EST starting 1/6. 1st chat dedicated to pharma. #fdasm
  • 09:01:16: Sermo Vitals Report Quantifies One Year of Physician Conversation About Diabetes: http://bit.ly/56ncnn #hcsm #fdasm
  • 09:17:39: @tmac1021 re: monitor -- are you referring to the USB blood-sugar meter? If so, I agree -- very cool. Wonder what diabetes peeps think?
  • 10:24:05: Very cool. Thanks! RT @ajstarks: @skypen here is the Pharma on Twitter Update Frequency http://flic.kr/p/7ox1pW #fdasm
  • 10:25:13: In case you missed it: This image is so powerful - speaks a 1000 words about the brave new world of digital health: http://bit.ly/6xVpv8
  • 10:34:00: Wall Street Journal: "Three Best Ways to Use Social Media" http://bit.ly/6s5xlz #hcsm #fdasm (via @TiphaineMF @martinmaynard)
  • 10:35:11: Funny. RT @pharmaguy: @devilishly_diab That's HO HO HO! re Pharma's Letter to Santa. http://bit.ly/4OBWhu
  • 10:46:27: Just finished reading a few minutes ago. Stay tuned. RT @fardj: @skypen: would love to get your thoughts on this: http://pbeye.info/134
  • 10:56:14: @ajstarks BTW, love that tweetfreq app you're using. Is it difficult to setup?
  • 13:14:47: Reading new post by @jonmrich: "Patients WILL Have the Final Say on Pharma Social Media": http://bit.ly/8IN71f #fdasm
  • 13:21:34: @jonmrich's post: patient ACTIONS, not words at pub. hearings, will ultimately have the most significant impact http://bit.ly/8IN71f #fdasm
  • 13:24:37: @jonmrich Q: if this entire process is about protecting public/patients, wouldn't the patient POV help inform what TO THEM "protect" means?
  • 13:29:44: Rock w/the stars of pharma social media -- join #fdasm podcast w/@fardj & @swoodruff at 4 PM EST w/@tobydiva: http://bit.ly/6mzqeG
  • 13:52:59: @Zero7KC re:DROID VS iPHONE consumer reports. Yes, but when you add "cell service satisfaction" VRZ wins. Booyaa! :) http://bit.ly/8SRjoR
  • 14:08:02: @Zero7KC : iphone on VRZ in 2010? My opinion: not a chance. Apple can't even talk to VRZ until their deal expires. My guess: mid/late 2011.
  • 14:21:27: @pharmaguy : 6 people at my office, 4 friends, and 2 family members now have #droid (incl. me), and the consensus is that #droid rocks.
  • 14:52:27: @pharmaguy trust me, I get it. Remember the "blackberry storm"? Useless piece of junk! #droid is in a diff. class. Not perfect, but superior
  • 14:54:33: @fardj @swoodruff great job on the diva podcast. gr8 pts. Advice to pharma. Fard: Remember the end-user. Steve: Start something now #fdasm
  • 15:02:25: @eyeonfda I can't believe you still have the storm. Wow. That's commitment.
  • 15:50:17: @jamielacey28 @ivanpacheco @bobharrell @pharmaguy: it's simple. if you have iphone envy, but love VRZ service, #droid is the ONLY way 2 go.

Tweets copied by twittinesis.com

buzz this

Thursday, December 17, 2009

From Twitter 12-16-2009

  • 07:08:10: K
  • 07:12:19: RT @JNJComm @MaverickNY Interesting point about lack of conversation - suspect it's due to concerns about what can/can't be discussed @skyp
  • 07:46:17: Let me think. Send u something soon.
  • 09:45:06: Pharma co twitter dashboard has been updated (and moved): check it out at http://www.PharmaTweeps.com #fdasm
  • 12:04:53: FDA, take note. Gov 2.0 kit from Microsoft. Next-gen enterprise-ready tech is ready to go. http://bit.ly/7NShaB (via @ahier) #fdasm
  • 12:07:38: @EileenOBrien - very cool on the Siren Interactive job. Met the folks at conference last month. GR8 people. Honorable niche. Good luck!
  • 12:14:39: Fact. TWTR always has problems. Fact: Virtually 0 support. Fact: Support page moved AGAIN! HERE IT IS: http://bit.ly/6vSFMk SHARE w/FRIENDS.
  • 13:50:00: RT @healthythinker: A father-to-be delivers baby via Google instructions on smartphone! http://bit.ly/5ICwMb
  • 13:51:33: All Gr8 bromances sooner or later come to an end. #bromancedeath RT @pharmaguy: @shwen Thx, bro. You may replace @skypen as my main man!
  • 14:31:54: Sanofi-Aventis is starting 2 give J&J a run for their social media $ - GoInsulin (YouTube), GoMeals (iphone), now this: http://bit.ly/4RWpgh
  • 14:39:03: This MIGHT be a first: pharma tweet which includes brand name directed to consumer w/info for AE reporting: http://bit.ly/5k1jmU Yes? #fdasm
  • 14:42:50: What is unacceptable? Were patients turned away? Did FDA promote poorly? @gfry @pharmaguy re: no patient rep. at #fdasm
  • 14:47:50: @SanofiVoices: terrific job w/the "Citizen Involvement Website" & "activation" campaign via social media. Way 2 keep it real. #fdasm
  • 14:49:17: @gfry - Really? I knew the awareness was low, did not know patients were turned away. I guess one led to the other. shame, really.
  • 14:52:23: @pharmaguy re: forgiveness vs permission-> others follow-> years pass-> people forget why-> a "1 click rule" world-> NOV-> shock-> hearings
  • 14:58:27: AZHelps tweet w/brand & info 4 AE reporting makes u wonder- what if instd of nexium it was seroquel (biopolar)...would they RT tweep's name?
  • 15:03:53: @gfry I was aware 2 months prior abt capacity issue, but I learned b/c I was submttng speaking topic. fdasm.com cam a month too late 2 help.
  • 15:05:38: How do you figure? RT @biocrowd @EileenOBrien looks like AZ is monitoring the ether and is after the tweeter, how creepy is that? #fdasm
  • 15:09:21: @biocrowd @EileenOBrien You're right. The original twt from no-longer anon peep here: http://bit.ly/74QBnW Pandora's box has blown its lid.
  • 15:10:14: @gfry re: "needs to be fixed". I completely agree. So what can WE do to help fix it? #fdasm
  • 15:12:15: @pharmaguy btw, terrific prep survey for your investor call. Your responses are 1 of the best #fdasm summaries so far. Worth a post.
  • 15:14:54: @BioCrowd re: req 4 AE - Isn't 1 of the #fdasm debates that pharma cos STILL shld make a reasonable effort regardless? my concern: privacy.
  • 15:18:27: @gfry : Again, totally agree, esp. abt building the future. Folks in the stream, ideas on what WE can do 2 bring the patient POV in? #fdasm
  • 15:20:35: @BioCrowd - re: patients best interests. Hmm. I am not going to assume that. However, makes me wonder how one could do this better.
  • 15:31:38: @gfry : Or create a hashtag - aggregate the discussions over a 1 week period -- and send via e-mail. Jst thinking about time :)
  • 15:40:45: Scenario: JOE twts abt issue w/brand 2 his 1 follower. Brand w/1MIL followers RTs Joe's twt w/AE reprt info. Now 1 MIL know Joe has issues.
  • 15:42:03: @gfry - I will certainly do all I can to help publicize them. I am sure others will help too. #fdasm
  • 15:49:34: @smartin511 re: Joe's risk. That's assuming Joe uses TWTR as a broadcast medium. But honestly, This is a very grey area, in my opinion.
  • 15:52:37: @smartin511 IMHO, this is an issue of discretion & proper use of channels. I applaud AZHelps, really. Just wondering how else to do this.
  • 15:54:33: @smartin511 - Technically, we are in absolute agreement. This is less abt regs, AEs, or HIPAA. Just trying to put myself in patient's shoes.
  • 15:58:04: @smartin511 : or perhaps a general RT message like "If you experience any issues on any of our products, click here". I dunno.
  • 16:00:48: @smartin511 Also, since in 1 click I can find out EVERYTHING about this person - including e-mail address - might that not be a better way?
  • 16:46:19: re: twt AE reporting @BioCrowd @MaverickNY @eileenobrien - Next time we chat to discuss how we think it can be done well/better :) #fdasm
  • 17:07:05: @swoodruff : I forgot, it's aleady happy hour there :)
  • 17:54:23: This image is so powerful, I can't even set it up. It speaks a 1000 words about the brave new world of digital health: http://bit.ly/6xVpv8
  • 18:31:40: Something so revolutionary should already need a "Guide for Dummies", but here it is: "GOOGLE WAVE FOR DUMMIES": http://bit.ly/4IgROv
  • 18:38:27: MUST READ 4 you and your friends, kids, family, clients. It's about YOUR PRIVACY. "FACEBOOK'S GREAT BETRAYAL" http://bit.ly/7Xs0Qy
  • 18:44:36: @Abeeliever no, trust me, I have yet 2 meet someone that has grasped it, let alone mastered it. This was written 4 all of us :) #waveidiot
  • 18:46:23: Re: "FACEBOOK'S GREAT BETRAYAL" article I tweeted a few minutes ago. I'm not one to propagate lies, so I checked for myself. Much is true.
  • 18:56:35: FACEBOOK PRIVACY UPDATE: The skinny: FB wants/needs page views-> must let search engines index-> previously private info now public.
  • 19:00:48: FACEBOOK PRIVACY FOLLOW-UP: A terrific guide for how to protect your privacy, 10 key things to do: http://bit.ly/67arCy
  • 19:03:43: @Abeeliever - Frankly, my concern is that this opens up children to being easily found & stalked. THAT was a huge hole for myspace.
  • 19:08:12: Scenario: 12-yr grl updates wall w/silly girl things. AS IF she'll undrstnd "google indexing" setting that now leads pervs straight 2 her.
  • 19:14:19: My Google-ready FB "public profile": Fabio is a fan of "HIV/AIDS Support Group", "MS Society", and "ADHD". kinda strange out-of-context :)

Tweets copied by twittinesis.com

buzz this

Wednesday, December 16, 2009

From Twitter 12-15-2009

  • 12:29:30: @zemoga: "What’s Your Pharma Wishlist for 2010?" [for FDA, pharma, HCPs, and patients]: http://bit.ly/5zMicO #fdasm
  • 12:39:18: RT @FDASM: New #FDASM-related articles added today from @whydotpharma @pfanderson @pharmaguy @devilishly_diab @zemoga: http://bit.ly/4HnscF
  • 13:21:29: Pharma Focus Presents: "Digital Pharma: A Year in Digital [parts 1 - 4]: http://bit.ly/8WLihk #fdasm
  • 15:10:33: U didn't click on the link did you?
  • 15:42:41: Twitter sending tweets to strangers. And we wonder why pharma is hesitant abt social media? TWTR, get ur sh#t together http://bit.ly/5n73fH
  • 15:47:17: bit.ly responds to Google & facebook's URL shortening services, launches BITLY PRO : http://bit.ly/5gfFFF
  • 15:52:26: Well said. RT @EdBennett: This [Twtr] is a company that tells you 2 "chillax" when they can't control spammers. Don't xpct an adult response
  • 15:56:51: Not jst polite, the law http://bit.ly/7Qua7U @hlane @GottaLaff: if you're going 2 RT someone, make sure u mention name of tweeter.
  • 16:00:43: Best customer support I have received in the past month: VERIZON, MYPUBLISHER. Terrific! #bestcustomersupport
  • 16:01:34: Anyone else finding that Twitter Search is down? http://search.twitter.com
  • 16:10:19: Twitter must hate me. RT @ritters90: @skypen Just used Twitter search about 4 mins ago
  • 16:11:32: Curious, if you search "from:skypen" do you get anything? RT @ritters90: @skypen Just used Twitter search about 4 mins ago
  • 16:12:26: @ritters90 re: bit.ly -- me too. Love TR.IM until they started "being overloaded" every 20 minutes.
  • 16:23:18: @ritters90 : Have you tried searching for "The invisible Man"? Sometimes I come up under that. ;)
  • 16:52:59: New post by @eyeonfda: "Google and Pharmacovigilance -- Can Search Save the FDA?": http://bit.ly/5s2nFh #fdasm

Tweets copied by twittinesis.com

buzz this

Tuesday, December 15, 2009

Pharma Focus Presents: "Digital Pharma: A Year in Digital"

PharmaFocus has released a series of "Digital Pharma" review articles available on PharmaFocus.com. I have collected the headlines and links here for easy reference. Some great stuff, worth taking the time to read. Enjoy!

# # #

12.9.09 : Digital Pharma: A Year in Digital (1/5)

Dominic Tyer kicks off Pharmafocus' review of digital developments with a whistle-stop tour of his online highlights this year.

12.10.09 : Digital Pharma: A Year in Digital (2/5)

Pharmafocus' review of digital developments in 2009 continues with thoughts from GlaxoSmithKline's Kai Gait.

12.14.09 : Digital Pharma: A Year in Digital (3/5)

Pharmafocus' review of digital developments in 2009 continues with Roche's Sabine Kostevc, who looks at initiatives outside pharma that impressed her this year.

12.15.09: Digital Pharma: A Year in Digital (4/5)

There's praise for Twitter and Physicians' social networks as our review of digital developments in 2009 continues with Bayer Schering Pharma's Len Starnes.

12.16.09: Digital Pharma: A Year in Digital (5/5)

Our review of 2009's top digital developments concludes with thoughts from Boehringer Ingelheim Pharma's John Pugh.
buzz this

From Twitter 12-14-2009

Tweets copied by twittinesis.com

buzz this

Sunday, December 13, 2009

From Twitter 12-12-2009

Tweets copied by twittinesis.com

buzz this

Saturday, December 12, 2009

From Twitter 12-11-2009

Tweets copied by twittinesis.com

buzz this

Friday, December 11, 2009

From Twitter 12-10-2009

  • 07:57:38: Who else will be joining the Healthcare Coalition call on #FDASM this morning?
  • 08:00:00: GOTO MEETING/CALL starts in 2 minutes: See Invitation from John Kamp: http://tr.im/He7O #fdasm
  • 08:01:12: @pfanderson : Really? Do you have every single video? Do you have permission from anyone yet?
  • 08:15:24: Discussing #FDASM on Healthcare Coalition Call, see slide: http://tweetphoto.com/6166286
  • 08:25:41: Discussing an e-bay like system ("trusted sellers") for healthcare information; could this work (WITH or IN ADD 2 FDA-approved seal)? #fdasm
  • 08:34:27: @bradatpharma @horationelson : Still curious if ROI for SM ala @skypen & @xpetit - see slides 60-70: http://tr.im/Heil
  • 08:42:33: GR8 @DIABETESMINE post "The FDA and Social Media", opinions on what the FDA needs to address: http://tr.im/HekR #fdasm
  • 08:45:38: An FDA Insider: "Those who planned the FDA public hearing were not on the same page as those who sent paid search warning letters" #fdasm
  • 08:47:37: An FDA Insider: "Frankly we were embarrassed abt the warning letters & part of the reason 4 pub hearings was 2 get things back on rt track."
  • 08:57:47: New Study: "Mobile Phone Technology May Address Unmet Needs of Parents of Children With Diabetes": http://tr.im/Heq3
  • 08:59:38: @mayorkl On the Healthcare Coalition call, someone said they spoke directly to the FDA and that is what they were told. I can get u name.
  • 09:04:51: Some people are EXTREMELY politically connected/aware of all the back-room wheeling-and-dealing regarding #FDASM. Frightening.
  • 09:14:31: Gr8 idea by HealthCentral re AE in SM: a Craig'sList-type "reply" system 4 pharma 2 inquire abt AEs http://tweetphoto.com/6168582 #fdasm
  • 09:18:28: Reminder: if anyone is having a twitter convo re #FDASM and needs >140 characters, get a room! A chat room, that is :) www.fdasm.com/chat
  • 09:19:43: Let me see what I can do 2 help. RT @pfanderson: Yes, we have all the #FDASM videos, but no permissions. Not sure how to contact...
  • 09:25:56: ATTENTION @accelmed @jonmrich @maureenmiller: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:26:11: ATTENTION @pnalen @CompassHC @TLGraham: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:26:56: ATTENTION @fardj @avandy @cmschroed: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:27:16: ATTENTION @drumbeat @wendyblackburn @markbard: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:27:41: ATTENTION @rohitbhargava @pharmaguy @ljpeck33: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:28:07: ATTENTION @donnawray @healthyjack @jbell99: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:28:27: ATTENTION @melissakdavies @mickelberg: Ur #FDASM Pub Hearing Video is ready 4 FREE YouTube posting. Need permission. Pls Reply & RT.
  • 09:28:43: @pfanderson - OK, let's see what happens :) #fdasm
  • 09:32:56: @planetrussell - crazy! re: Chihuahua crisis. I recently got one - most incredible dog in the world! Peeps, u must adopt!
  • 09:36:19: Pls RT this message: "@pfanderson has EVERY SINGLE #FDASM video ready 4 posting on YouTube, jst need speakers 2 say YES. Help us find them!"
  • 09:36:57: Awesome -- thank you for the permission @avandy (cc: @pfanderson) #fdasm
  • 09:38:40: HAHA! He gets real excited! RT @planetrussell: @skypen Does your Chihuahua like watching the movie version of himself?
  • 09:40:11: @planetrussell "Hotel 4 Dogs", "Beverly Hills Chihuahua", even "Bolt" -- he loves all that stuff! Animal Planet rescue kinda freaks him out
  • 09:41:37: @cmschroed 1. Say YES. 2. Re-Tweet 3. Help track down other speakers who might not be on twitter. THANKS! (cc: @pfanderson) #fdasm
  • 09:42:30: Rick, you rock! RT @rdublife: @pfanderson I spoke at #fdasm please dm me for email info so we can work out permissions
  • 10:14:55: New SOCIAL MEDIA REPORT from Marketing Profs. Sample chart: video use by industry http://tr.im/HeQk Biotech #2? more info http://tr.im/HePP
  • 11:31:47: Is link correct? RT @GrayscaleFDA: Extraodinary food for thought control for FDASM. have a look here: http://bit.ly/79gb5
  • 11:34:52: THANK YOU @mickelberg @jonmrich @fardj @cmschroed @skypen @avandy @MelissaDavies @rdublife 4 permission 2 post ur #FDASM on YouTube, others?
  • 12:30:56: Any1 know more abt this 8/19 story? Pfizer & Private Access Announce Plans 2 Dvlp Online Community 2 Accelerate Clin Rsrch http://tr.im/Hfyx
  • 12:41:23: FASCINATING, must-read: "Health Insurers Caught Paying Facebook Gamers Virtual Currency To Oppose Reform Bill": http://tr.im/HfCY #fdasm
  • 12:48:39: "Virtual Astroturfing", a whole new level of deception? Grassroots campaign leverages Gambit "Virtual Currency" platform. http://tr.im/HfCY
  • 12:52:17: MOL Global acquires FRIENDSTER. Does anyone care? Asia does, where Friendster is leading Website w/over 75 MIL REG USERS! http://tr.im/HfGy
  • 12:54:52: Check it out -- new Google LABS project "LIVING STORIES", collaboration w/NYT & Wash Post: http://livingstories.googlelabs.com/
  • 13:05:12: Tried the new "GOOGLE GOGGLES" visual search on my #Android ... GR8 idea, but was 0 for 3 on my pics :( http://tr.im/HfL7
  • 15:13:54: Agency people have failed to educate legal & regulatory depts at pharma on social media: http://tr.im/HgsP (@jbselz @PRforPharma) #fdasm
  • 15:19:30: @alexdcrx @jbselz @prforpharma 1 gr8 resource 4 explaining Social Media, Commoncraft's "In Plain English" series: http://tr.im/HguR #fdasm
  • 15:26:34: My newest follower is "Farf's Wife". I don't know Farf, and certainly don't want him to get the wrong idea! #strangefollowers
  • 15:34:39: @alicia189 - can you repost link - perhaps use a shortener - didn't work. Thanks!
  • 18:36:43: @jbell99 -- it needs to be cut-up and uploaded ... @pfanderson is doing this for us ! So not sure exactly when, but will let u know
  • 18:50:17: @theartostu you too! Look forward to seeing u next week. Don't forget to check out www.fdasm.com. Night.
  • 22:11:00: Or a collar sticking up? @WendyBlackburn: @skypen Fabio- re: video, you have permission, as long as there's nothing hanging out of my nose

Tweets copied by twittinesis.com

buzz this

Thursday, December 10, 2009

Coalition of health insurance groups use social networking games

Written by Jaimy Lee
December 10 2009
Source: PR Week

Media reports are questioning a coalition of health insurance trade groups that is offering Facebook users "virtual currency" if they send letters protesting healthcare legislation to members of Congress.

"Virtual currency" can be used to purchase virtual products in social networking games like Mafia Wars.

The Get Health Reform Right coalition includes America's Health Insurance Plans, the BlueCross BlueShield Association, the Healthcare Leadership Council, and the National Retail Association.

buzz this

Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research

Privacy-enhanced search technology addresses privacy concerns to increase patient participation

Source:Pfizer Media Room
Published on August 19, 2009

NEW YORK--(BUSINESS WIRE)--Recognizing that patient participation in clinical trials is the key to progress in medical research, Pfizer Inc announced today that it has entered into a collaboration with Private Access, the innovator in privacy-enhanced search technology, to create a new online community aimed at increasing clinical trial awareness and participation. The site will be the first to focus on patient privacy rights to connect patients, physicians and researchers with tailored information, tools and technology that will lead to more informed decisions about patient care, including clinical trial participation industry-wide.

Pfizer’s collaboration with Private Access will help address patients’ and physicians’ top concerns regarding research and clinical trials. The companies will work toward reducing the time needed to develop new and improved treatments by making it possible for researchers and investigators -- based on express private access rights granted by the patient -- to conduct more focused searches for clinical trial candidates.

Private Access’ patented technology allows patients to control to whom, and for what purposes, they grant access to see all or selected portions of their personal health information. By granting “private access” only to researchers focused on the conditions that interest them, patients can be more quickly and precisely matched to appropriate clinical trials while simultaneously protecting their confidential personal health information.

Nearly 85 percent of patients in a recent survey stated they were unaware that clinical trials were a possible treatment option, and 31 percent of physicians surveyed did not refer patients to trials due to, among other things, lack of information. According to a study commissioned by the Institute of Medicine (IOM), the number one reason patients who were aware of trials were not willing to participate was fear that their health information would not remain confidential.

“Many patients who could benefit from participation in clinical trials don’t enroll in them because they are not aware that potentially relevant research is under way or they cannot find a specific trial to meet their needs; others worry that they will lose control of their health information,” said Freda Lewis-Hall, M.D., Pfizer’s chief medical officer. “With unprecedented collaboration among key groups, Pfizer and Private Access believe we can build the preeminent online clinical trial community to be used industry-wide to share knowledge while giving patients the confidence and control to share their health information.”

The costs to find and enroll patients into clinical trials more than doubled between 2000 and 2005, and continue to climb. With study protocols becoming more complex, the number of clinical research studies increasing to more than 35,000 and patient participation in clinical trials declining, effective patient recruitment is a critical factor in successfully bringing new treatments to patients.

“A privacy-enhanced search engine for personal health information enables patients to simultaneously address their privacy concerns and improve access to care,” said Robert Shelton, founder and CEO of Private Access. “It is great that the Internet can be used today to find publicly available information for free in seconds or to locate potential employees for a small fee in minutes, yet it still takes months or years and often thousands of dollars per patient to locate individuals for clinical trials that might save or improve lives.

“By introducing technology that honors each patient’s privacy needs, we can leverage the efficiency of Internet-based search for clinical trial patients – speeding up the recruitment process and the discovery of new treatments,” Mr. Shelton continued.

Pfizer and Private Access will work together to bring a wide range of partners to the online community, including additional clinical trial sponsors, patient advocacy groups, technology providers, and other key public and private stakeholders. The portal will also encourage social networking on the clinical trial experience. The new platform and online community will be rolled out in phases, starting in late 2009.

"Patients are the most important stakeholders in medical research. By merging respect for their privacy with access to relevant and actionable medical information, we are giving patients more control over their destinies," said Greg Simon, senior vice president for worldwide policy at Pfizer. "This collaboration has the potential to accelerate medical progress by putting patients' needs front and center."

About Private Access, Inc.

Private Access, Inc. is making it safe for sensitive personal information such as medical records to be accessible over the Internet. We accomplish this with technology that allows each person to grant private access to all or selected parts of their confidential personal information to doctors, family members, researchers and others based on their particular needs and interests. Our people and technology platform, as well as the applications we build, are all dedicated to empowering individuals to improve the care they receive, accelerate the discovery of new treatments for diseases and chronic illnesses that affect them or others they care about, and reduce health care costs for their families and the nation. Founded in late 2006 upon issuance of its core patent, Private Access is headquartered in Irvine, California.

Pfizer Inc: Working together for a healthier world™

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with health care providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

buzz this

Mobile Phone Technology May Address Unmet Needs of Parents of Children With Diabetes

Mobile Phone Technology May Address Unmet Needs of Parents of Children With Diabetes, Sending Blood Sugar Readings Via Text, to Help Manage Child's Illness

According to new study conducted by the Center for Connected Health, parents most concerned about access to their child's healthcare provider

Source: Pr Newswire

BOSTON, Dec. 8 /PRNewswire-USNewswire/ -- In a recent study conducted by the Center for Connected Health, a division of Partners HealthCare, new data revealed that parents of children with diabetes were receptive to using novel health technology - such as a mobile phone that could collect and transmit the child's blood sugar readings to a doctor - to help manage their child's diabetes. This study was published in the November issue of the Journal of Diabetes Science and Technology (Volume 3, Issue 6, November 2009).

Over two-thirds (69.3%) of the parents of children with Type 1 diabetes (n=125) and Type 2 diabetes (n=77) completing an online survey had a 'very positive' response to the proposed mobile phone glucometer (blood sugar or glucose monitor) prototype. More than half of parents expressed interest in signing up for the service.

Parental concerns and the willingness to adopt mobile-phone-based technology to help monitor and communicate their children's diabetes are likely tied to the unmet need of parents, including provider access, limited available information and support, and the complex management of children with diabetes. Nearly 30% of parents (27.7%) reported they would 'definitely sign up' for the prototype mobile phone glucometer service, and another 27.7% reported they would 'probably sign up.'

"Parents are often the primary caregivers for children with diabetes, and they must learn to adjust their child's treatment based on signs and symptoms, which can vary from day to day. This can be extremely challenging during a child's transition to adolescence," said Alice Watson, MD, MPH, Corporate Manager, Center for Connected Health.

"This study demonstrates that parents of children with diabetes are interested in using mobile phone technology to help manage their child's illness, which further illustrates the belief that technology offers a solution," added Venessa Pena, first author.

Overall, parents expressed most concern with access to their child's provider, with 84.9% of parents wanting shorter waiting times and 78.7% easier phone access to their physician. 77.8% stated they would like to be able to contact their provider via email to discuss their child's diabetes.

"These study results provide strong evidence for the link between current problems in our medical system and the willingness for parents to adopt new technologies that can overcome these problems," said Joseph C. Kvedar, MD, director, Center for Connected Health. "Increased enthusiasm for the use of communications technology in patient care management is helping to overcome traditional barriers to technology adoption, making the use of these technologies in clinical practice more feasible."

Diabetes is one of the most common chronic diseases in children and adolescents; about 151,000 people below the age of 20 years old have diabetes (Centers for Disease Control). Each year, more than 13,000 children and adolescents are diagnosed with type 1 diabetes. The obesity epidemic and a low level of physical activity among young people is contributing to an increasing number of children with type 2 diabetes, a disease usually diagnosed in adults over 40 years old. According to the American Diabetes Association, one in every 400 to 600 children and adolescents has Type 1 diabetes, and 2 million adolescents (1 in 6 overweight adolescents) aged 12-19 have pre-diabetes.

About the Center for Connected Health

The Center for Connected Health, a division of Partners HealthCare, is creating effective, new solutions and innovative interventions to deliver quality patient care outside of the traditional medical setting. Our programs use a combination of remote-monitoring technology, sensors, and online communications and intelligence to improve patient adherence, engagement and clinical outcomes. The Center also offers expert online second opinions, enhanced medical education and training, and engages in innovative research to discover new pathways to better care, including the use of virtual worlds and online coaching. Visit www.connected-health.org.

Boston-based Partners HealthCare is an integrated health system founded in 1994 by Brigham and Women's Hospital and Massachusetts General Hospital. In addition to its two academic medical centers, the Partners system also includes community and specialty hospitals, community health centers, a physician network, home health and long-term care services, and other health-related entities. Partners is one of the nation's leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Partners is a non-profit organization. Visit www.partners.org.
buzz this

From Twitter 12-09-2009

  • 00:39:58: "Greg Matthews, Humana: future of health brands and Social Media" (via @roskadigital @jbselz @ericbrody): http://tr.im/H5EL #fdasm
  • 08:45:33: MUST READ: New CAREGIVER STUDY (PDF) from AARP reveals 29% of US adult population (65.7 million people) are caregivers: http://tr.im/H7D5
  • 08:53:42: CAREGIVER STUDY: 53% of caregivers used Web 2 find caregiving info-78% of these 2 find condition/treatment info http://tr.im/H7D5 #fdasm
  • 08:58:02: Caregiver Math: 78% (condition/treatment info search) of 53% (use Web) of 29% (US caregivers)= 27 mil adults. Huge. http://tr.im/H7D5 #fdasm
  • 09:11:44: Creator, critic or collector? Forrester's SOCIAL TECHNOGRAPHICS Profile Engine now updated w/2009 data: http://tr.im/H7LN (via @Ideagoras)
  • 09:14:26: Fantastic! Thank you! RT @pfanderson: #FDASM Videos YouTube PLAYLIST http://tr.im/H7NA
  • 09:18:06: Agree! @pfanderson: The FDA should have created playlist of INDIVIDUAL videos from #fdasm hearing organized by day/speaker http://tr.im/H7NA
  • 09:35:50: New post from @jonmrich "Monitoring Adverse Events in Social Media for Pharma’s Biggest Brands": http://tr.im/H7Uk #fdasm
  • 09:45:58: @jonmrich & @MelissaKDavies explore specific pharma brands 2 undrstnd if monitoring 4 AEs in SM is a hopeless task http://tr.im/H7Uk #fdasm
  • 10:03:51: Listening 2 Insights & Perspectives re: #FDASM w/Jonathan Richman (@jonmrich) & Lilly's Mel Halkyard (melhalkyard) ePharma Summit webinar
  • 10:07:22: Anyone using a specific hashtag for the ePharma Summit webinar going on now? #epharmafda ? #epharmawebinar ? Just pick one?
  • 10:08:39: #ePharmaFDA: @jonmrich: the session on Adverse Event reporting received the most attention @ #fdasm publich hearings
  • 10:09:05: #ePharmaFDA: What should manufacturers be responsible for? #fdasm
  • 10:10:07: #ePharmaFDA: @jonmrich: Is company responsible for sites you create and control, or everything online? #fdasm
  • 10:11:23: #ePharma Webinar: @jonmrich: If, for example, you edit an entry on wikipedia once, are you responsible in perpetuity? #fdasm
  • 10:12:32: "#ePharm" Webinar -- will be using Shwen's suggestion for the rest of the call. #epharm #fdasm #hcsm
  • 10:13:06: ePharm Question: is there one specific Q that you hope is answered when FDA releases guidance? #fdasm
  • 10:14:15: #ePharma Webinar: @melhalkyard: We'd like to hear clarity on WHAT we are responsible for exactly -- for ex, not the whole web! #fdasm
  • 10:15:26: #ePharma Webinar: @jonmrich: re: AE reporting & FDA's MedWatch form. No incentive for consumer to fill out this form. #fdasm
  • 10:16:08: #ePharm Webinar: @jonmrich: we need clarification on what exactly is a "reportable adverse event" for ex, is twitter handle enough? #fdasm
  • 10:17:10: #ePharm Webinar: @jonmrich: referencing his great blog post from today re: AEs: check it out: http://tr.im/H7Uk #fdasm
  • 10:19:13: #ePharm Webinar: @melhalkyard: Despite data showing only 1/500 AEs meet all 4 criteria, we might be responsible 4 reporting more #fdasm
  • 10:22:56: #ePharm Webinar (live now!): @jonmrich: Risk turning pharma cos into private investigators if criteria for AE reporting not reasonable Fdasm
  • 10:24:10: #ePharm Webinar (live now!): @melhalkyard: until now, it's abt the message, not the channel. Now, that clearly seems to have shifted #fdasm
  • 10:24:53: #ePharm Webinar (live now!): @melhalkyard is referring to the "intergalactic task force" :) #fdasm
  • 10:25:51: #ePharm Webinar (live now!): @melhalkyard: From what i understand, everyone that asked to present at hearings was given opp #fdasm
  • 10:26:31: #ePharm Webinar (live now!): @melhalkyard: If there's compelling data that people can provide, that would be useful to FDA #fdasm
  • 10:28:07: #ePharm If you have questions for the FDA re: "next steps", don't forget to submit here: http://tr.im/GDXB #fdasm
  • 10:28:46: #ePharm Webinar Question (live now!): What can companies do today in light of fact there is no guidance? #fdasm
  • 10:30:12: #ePharm Webinar (live now!): @melhalkyard: only when u understand WHAT people are talking abt online, can u consider possibilities #fdasm
  • 10:31:18: #ePharm Webinar Question (live now!): Thoughts abt Social Media for clinical trial recruitment? #fdasm
  • 10:32:12: #ePharm Webinar (live now!): @jonmrich: Novartis has a twitter accnt for clinical trial recruitment: @NovartisTrials #fdasm
  • 10:33:01: #ePharm Webinar Question (live now!): Where there any presentations about e-rep programs at the hearings? #fdasm
  • 10:33:46: #ePharm Webinar Question (live now!): Cool! @jonmrich, thanks for the www.fdasm.com plug! #fdasm
  • 10:34:27: #ePharm Webinar (live now!): @melhalkyard: Lion's share of conversation at hearings were related to consumers #fdasm
  • 10:35:32: WWW.FDASM.COM -- links to all the info you need regarding FDA & Public Hearings. #fdasm #epharm #hcsm
  • 10:36:27: #ePharm Webinar ending ... link to archived version coming soon, and will be available on fdasm.com. Great job @jonmrich & @melhalkyard!
  • 10:38:10: Yes, FDA/CDC savvy when it comes to communicating w/consumers, but have not leveraged the tools for purposes of comm w/#fdasm stakeholders
  • 10:47:42: Future note to all folks hosting webinars: Select, Publish & Publicize a simple & unique HASHTAG for your event. #fdasm #hcsm #epharm
  • 10:52:47: Everyone knows this, right? Monday Google launched "live real-time search", includes twitter. For exmp, fdasm: http://tr.im/H8mi #fdasm
  • 11:10:21: GREAT Post by @jonmrich re: AE reporting in Social Media now w/7 key takeaways: http://tr.im/H7Uk #fdasm
  • 11:20:18: @ddwebster hmmm. wasn't bob's article originally posted on 11/20? Is this different? http://tr.im/H8y9
  • 13:22:20: Great! RT @SusannahFox: But stay tuned: @Pew_Internet will have our own #caregiver study out soon (yes, including social media use) #fdaSM
  • 13:23:02: You are welcome! RT @treatheadlice: Thank you @skypen for providing content like this Google study @ fdasm.com http://bit.ly/4drCJ4 #fdasm
  • 13:28:26: SPECIAL THANK YOU 2 @jonmrich @eyeonfda @pharmaguy @whydotpharma @wendyblackburn 4 being "Creators" & giving us new stuff 2 read this week!
  • 13:33:29: @gfry re: Isn't every patient & caregiver an e-patient? I wish we cld suddenly jump into twitter-chat-mode & discuss this in >140 characters
  • 14:46:53: @gfry alright, give me a few minutes.
  • 14:59:28: @gfry Let's try this so others can join too: http://www.fdasm.com/chat/ #fdasm chat
  • 15:01:16: @gfry : let me know when you jump in -- just pick a screen name and u should see me.
  • 15:05:02: @ePatientDave @susannahfox: u r welcome 2 join @gfry & I 2 discuss patients, caregivers, e-patients-why the difference? www.fdasm.com/chat/
  • 15:14:25: @alexdcRx Alex, so you're "AlexdcRx" now? Weren't you @AlexDC before? You have 18,000 followers w/that accnt -- that's mighty impressive!
  • 15:25:39: @alexdcRx : aha! I look forward 2 seeing ur tweets. I'm sure u already follow all these gr8 folks: http://www.ignitelabs.com/pharmatweeps/

Tweets copied by twittinesis.com

buzz this

Wednesday, December 09, 2009

From Twitter 12-08-2009

  • 07:48:05: RT @FDASM: FDASM Update: Transcripts from hearings now available on www.fdasm.com. #fdasm (@pharmaguy)
  • 10:53:24: Facebook alert. More changes on the way. Be ready. http://tr.im/H2b6
  • 14:33:27: Coalition 4 HC Comm. meeting on FDA pub hearings, reflections on ideas proposed, a call 2 keep the #FDASM movement alive http://tr.im/H3ra
  • 14:47:08: I look forward to it Amy! RT @DiabetesMine: I have my own post coming out on #fdasm real soon!
  • 14:56:53: @eyeonFDA: "FTC New Efforts Regarding Endorsements Testimonials": http://tr.im/H3zg #fdasm
  • 15:40:15: Coalition for Healthcare Communications to discuss FDA public hearings. See their perspectives here: http://tr.im/H3ra #fdasm
  • 17:01:24: Thanks for sharing. RT @roskadigital: Pharma gains back control over Google's Sidewiki http://ow.ly/K3DM #fdasm #hcsm #hcmktg
  • 20:03:15: @jonmrich I really said that, didn't I? FDA's response was: "I don't think I've ever heard anyone ask for an intergalactic taskforce". :)
  • 20:18:34: Simply put: HTML cut into 3 columns. Sproutbuilder controls left and right columns, center us widgetbox.
  • 20:19:52: Sproutbuilder is composed of mutiple feeds, mostly pubicly available RSS feeds.

Tweets copied by twittinesis.com

buzz this

Tuesday, December 08, 2009

FDA Public Hearings: Closing Remarks by Tom Abrams, director of FDA's DDMAC

Extracted from Day 2 (Nov 13, 2009) transcript of part 15 Public Hearing "PROMOTION OF FDA-REGULATED MEDICAL PRODUCTS USING THE INTERNET AND SOCIAL MEDIA TOOLS"

Tom Abrams:

"Wow, we made it through the two days. I just have a few closing remarks. We had a very full two days of interesting, diverse, and useful comments.

Taking a step back and looking at FDA's objective, we want consumers and healthcare professionals to have accurate, balanced, and timely information about medical products. FDA needs to ensure that promotion of medical products is not misleading and is balanced.

This objective is the reason why we conducted this two day hearing.

The Internet -- we've heard a lot about the Internet and social media tools. What we have heard is it's a different medium. It's one that provides information. It's rich in the information it can provide. At the same time, it's one that presents challenges.

Therefore, FDA wants to give this much thought as we determine the best approach to the Internet and social media tools.

FDA has much work to do in this area and one that we are determined to do. It's important and we will do it.

We want to have the involvement of our stakeholders. This hearing has been an excellent meeting. It has provided us a wealth of information, comments, and data. FDA encourages our stakeholders to submit your comments, information, and data to the open docket. As a reminder, the docket is open until February 28 of 2010.

Next steps -- I know that's the big question. FDA's next steps include the review of all this information. We will do this carefully so we get this right. It's too important of an area not to do it right as we want the best information about medical products for consumers and healthcare professionals.

The FDA panel would like to thank the speakers for their presentations and all the valuable information they shared today and yesterday. We want to thank all the folks in the audience, both here and viewing this by webcast for their attention and participation listening and interest in the meeting.

We would also like to thank Rochelle and Anton of the NTSB staff for their terrific, simply terrific, assistance and guidance with this hearing. They made it much easier for us.
We also would like to thank all the folks in FDA that worked real hard to make this hearing possible. It was not the easiest thing that these folks put together.

Frankly, there's too many from FDA that worked on this to name them individually. You met many of them in the lobby today and yesterday.

However, we would like to recognize two FDA folks who have done an incredible job of coordinating this hearing. They are Jean-Ah Kang and Barbara Chong. Thank you, Dr. Kang and thank you, Dr. Chong for your incredible work and hard work on this. We all appreciate it.

To all the attendees and speakers and staff, have a safe trip home. The meeting and now hearing is now adjourned."
buzz this

Coalition for Healthcare Communication Meeting on the FDA Public Hearings, Reflections on Ideas Proposed, and a Call to Keep the FDASM Movement Alive

Dear Readers,

On Thursday December 10th John Kamp, Executive Director, Coalition for Healthcare Communication, has organized a meeting to discuss the recently-held FDA public hearing on the use of the Internet and Social Media; specifically, to reflect on what was said and discuss next steps. A document that was put together by Mr. Kamp reflects the coalitions perspectives regarding several topics presented at the meeting. Below is an outline of that document. Click here if you wish to download the full document in PDF format.

Most promising ideas
  • Create a system to flag and click to risk data
  • Develop a system to elevate all FDA regulated content
  • Reverse course on the "one click away" warning letters
  • Clearly state that without control, companies have no responsibility
  • Make the AER process much more patient and company friendly
  • Coordinate enforcement against internet health scams
Most Difficult to Implement
  • Reverse the FDA position that "one click is insufficient"
Most Unrealistic or Otherwise Bad Ideas
  • Enshrine existing AER reporting and pay for expansion with user fees
  • Send AERs directly to FDA
  • Create a new FDA advisory committee
Next Steps
  • Think this over and make suggestions at the December 10 meeting
  • Reach out to the wider network
  • Develop a short "consensus comment" from a broad array of industry players, a
  • "consensus of the willing"
  • Start developing the AAAA/Coalition FDA Comment now
Along with this document Mr. Kamp also included the following message message which directs those who were sent the invitation to the Dec. 10 meeting to take the following action items:

# # # Excerpt from Mr. Kamp's Message # # #

"Please come prepared to offer writing support for sections of the comment.

Reach out to the wider network. I suggest we try to involve the pharma companies that participated, PhRMA, AdvaMed, IAB, the media companies, including Google, Health Central, WebMD, Waterfront, Sermo, Patients Like Me, etc. If you have contacts or ideas or other resources for this outreach process, we want to hear about it.

Develop a short "consensus comment" from a broad array of industry players, a "consensus of the willing." If there are enough "willing," this could be very powerful comment to FDA, particularly if we could get a consumer group or patient group to join. If you have suggestions, make a list for us.

Start developing the AAAA/Coalition FDA Comment now. Outline what we might best say, starting with our points for the FDA presentation, adding data and other compelling content. We will have a draft outline by the December 10 meeting and will be asking you to contribute to sections."

# # # End of Excerpt # # #

The reason I am sharing this with all of you is that you ARE my wider network -- and, in my opinion, you ARE the coalition of the willing.

What you choose to do from here is up to you. However, I strongly urge (regardless of whether you choose or care to attend this particular meeting) that we all continue to share information with each other -- as this is the only way we are going to be the kind of coalition that can effect change. Whatever you share with me (unless you explicitly request otherwise) will be posted on www.fdasm.com and make it visible to as many people as possible. So please, keep sharing, keep discussing, keep debating, and help keep the movement alive.


Fabio Gratton

buzz this

From Twitter 12-07-2009

  • 11:49:04: Happy Monday @heldincontempt @shwen @eyeonfda @ellenhoenig @MarianCutler @jeannemale @swoodruff @whydotpharma @skypen @andrewspong @jonmrich
  • 13:11:33: Say "no" to toxic chemicals found in household products. Join the Million Baby Crawl #MBCrawl http://www.millionbabycrawl.com
  • 16:21:53: Yes, white elephant=no patients! RT @whydotpharma: Was there a white elephant in the FDA hearing? http://bit.ly/4U9gom #hcsmeu #hcsm #fdasm
  • 17:40:24: Brilliant! "MIT team wins Darpa's treasure hunt in less than one day". How? Make everyone a player! http://tr.im/GXXI #hcsm
  • 21:03:30: The most important document you will download in the next 6 months -- THE SCHEDULE FOR THE 2010 FIFA WORLD CUP (PDF): http://tr.im/GYIp

Tweets copied by twittinesis.com

buzz this

Sunday, December 06, 2009

From Twitter 12-05-2009

Tweets copied by twittinesis.com

buzz this

Saturday, December 05, 2009

From Twitter 12-04-2009

Tweets copied by twittinesis.com

buzz this

Friday, December 04, 2009

Motorola Survey Reveals Shift in Media Consumption Habits Across Generations

Connectivity and access to personal content transcends generations in North America

Download Motorola’s Media Engagement Barometer: Fast Facts (PDF)

Source: Motorola Media Center

HORSHAM, Pa. – December 3, 2009 – The 2009 Media Engagement Barometer commissioned by Motorola’s Home & Networks Mobility business (NYSE: MOT) has revealed a shift in consumer influence that hasn’t been widely recognized yet: Age no longer dictates a consumer’s willingness or ability to use media technology or services. In fact, all generations – Millennials (75 percent), Gen Xers (74 percent) and Boomers (66 percent) – recognize the role entertainment technologies play in helping them keep their lives in order, which helps explain why Millennials (80 percent), Gen Xers (78 percent) and Boomers (78 percent) are equally likely to desire to be constantly connected.

With all generations now immersed in entertainment technologies, we must look beyond age to predict influences.
  • Connectivity is more of a lifestyle issue. Being accessible at all times is seen as a necessity across generations (Millennials, 79 percent; Gen Xers, 64 percent; Boomers, 65 percent).
  • There is a two-way dialogue between consumers of all ages as they engage with technology products and share their experiences. The majority of Americans report influencing the decisions of their children (75 percent), friends (74 percent), colleagues (67 percent) and parents (58 percent).
  • Parents, grandparents and children alike are actively engaged in the tech sphere of influence. Gen X and Boomer parents reveal that they are influencing their children’s tech habits (Gen Xers, 87 percent and Boomers, 79 percent) even more than their Gen X (62 percent) and Millennial (76 percent) children influence their habits.
“In understanding the shift in media consumption habits, Motorola is able to develop products and services that will enable our customers to accelerate the delivery of personal media experiences,” said Dan Moloney, president of Motorola’s Home & Networks Mobility business. “The barometer findings have demonstrated how networking technologies have had a really powerful impact in integrating the different facets of people’s lives, and the “digital generation divide” that we perceived to dictate technology is now shifting toward a usage-based definition.”

The purpose of the study was to explore how different generations engage through technology products and services with family, friends and colleagues. Interviewers questioned a survey sample of 1,000 Americans ranging from 16-64 years old. However, as technological innovations continue to progress, people’s lives can no longer be so easily segmented. Millennials, Gen Xers and Baby Boomers come together through technology, forming bonds based on usage habits rather than age group.

“Service providers and technology companies are starting to deliver video, communications and information services more aggressively across multiple devices. However, if the key to success for these new services is consumer acceptance, adoption and loyalty, then it’s critical we understand the consumer influence model – which has obviously shifted – and then also shift our development and marketing strategies to align with consumer influences and habits,” said Eduardo Conrado, chief marketing officer for Motorola’s Broadband Mobility Solutions businesses.

Connectivity Is a Necessity
The ability to connect wherever you are has become an essential component of daily life. In fact, seven in 10 Americans (70 percent) feel it’s “important for me to always be accessible,” and nearly eight in 10 (78 percent) feel they are constantly connected with family, friends and colleagues, regardless of physical location.

This level of access gives Americans the freedom to better prioritize and blend different aspects of their lives. Rather than feel stifled by their constant availability, Americans admit that being connected makes them feel relaxed and confident.

Demand for Content Anytime, Anywhere
In spite of their everyday use of technology, 70 percent of those surveyed are still excited by the ability to live a connected lifestyle and, regardless of where they are, have become reliant on the ability to access and share content, including video images, anytime, anywhere. Sixty-six percent of Americans expect to be able to access the same content no matter where they are.

Universal Need for Customization
In addition, Americans need an effective way to cut through the clutter and learn about customizable solutions that meet their needs, as many are frustrated and overwhelmed by current levels of information. That’s why Americans of all ages, not just Millennials, now recognize the value in making their content and experiences personal. The desire to customize individual experiences extends from media consumption to social networking to watching and interacting with their televisions.

As of today, the majority of Americans (57 percent) across all generations have received a customized recommendation from a program based on their individual tastes, and roughly half of those have received a customized suggestion have acted on it (44 percent).

Sphere of Influence
Traditionally, Millennials have been touted as the “tech generation” and viewed as the primary influencers on their parents’ technology purchases and behaviors. Motorola’s 2008 study among Millennials revealed that 71 percent of Millennials have influence over parental decisions about cable, DSL or dish-satellite services (SOURCE: “Motorola Home and Networks Mobility Millennial White Paper,” 2008).

However, as evidenced in the Media Engagement Barometer findings, parents are influencing their children’s tech decisions as often as – if not more than – their children are influencing them. That’s why it is time to reevaluate our understanding of the sphere of influence. Regardless of age, consumers are turning to cross-generation tech influencers who are defined by their media consumption habits.

For more information on Motorola’s 2009 Media Engagement Barometer, please visit www.motorola.com/mediaengagement

# # #

About Motorola’s Media Engagement Barometer
Motorola’s Media Engagement Barometer was created to explore the shifts in media consumption – functionally and emotionally – across all generations. It was designed to help Motorola understand consumers’ everyday behaviors and social experiences wherever they are to gain insights into emerging social trends and future desires for engaging with others and accessing content through entertainment and home networking devices and services.

A 15-minute telephone survey was conducted among a census representative sample of 1,000 Americans age 16-64. Interviews were conducted between August 28, 2009 and September 11, 2009. The margin of sampling error at the 95 percent level of confidence is ±3.1 for total respondents (1,000). The research was conducted by StrategyOne, an applied research consulting firm. For more information, please visit http://www.strategyone.net/.

About Motorola
Motorola is known around the world for innovation in communications and is focused on advancing the way the world connects. From broadband communications infrastructure, enterprise mobility and public safety solutions to high-definition video and mobile devices, Motorola is leading the next wave of innovations that enable people, enterprises and governments to be more connected and more mobile. Motorola (NYSE: MOT) had sales of US $30.1 billion in 2008. For more information, please visit www.motorola.com.
buzz this